We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

111 hedge funds and large institutions have $266M invested in GenMark Diagnostics, Inc in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 28

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

1% more funds holding

Funds holding: 110 → 111 (+1)

17% less capital invested

Capital invested by funds: $320M → $266M (-$53.9M)

Holders
111
Holders Change
+1
Holders Change %
+0.91%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
49
Reduced
28
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.79M
2
NIM
Needham Investment Management
New York
+$3.01M
3
Bank of America
Bank of America
North Carolina
+$2.35M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.04M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.89M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$2.49M
3
Millennium Management
Millennium Management
New York
-$1.86M
4
MAG
Millrace Asset Group
Pennsylvania
-$1.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.69M +$63.1K +11,444 +3%
Charles Schwab
27
Charles Schwab
California
$1.56M +$46K +8,334 +3%
EIM
28
Essex Investment Management
Massachusetts
$1.45M +$78.1K +14,165 +5%
Deutsche Bank
29
Deutsche Bank
Germany
$1.33M +$93.1K +16,879 +7%
QI
30
QS Investors
New York
$1.29M – – –
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.27M +$59.6K +10,800 +4%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$1.18M +$907K +164,491 +204%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.16M +$34K +6,157 +3%
Squarepoint
34
Squarepoint
New York
$1.14M -$257K -46,533 -16%
Wells Fargo
35
Wells Fargo
California
$1.07M +$72.9K +13,211 +6%
PAM
36
Panagora Asset Management
Massachusetts
$889K -$236K -42,806 -19%
Citadel Advisors
37
Citadel Advisors
Florida
$790K -$1.13M -205,304 -56%
OAM
38
Oxford Asset Management
United Kingdom
$593K -$326K -59,115 -32%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$537K +$223K +40,400 +57%
Millennium Management
40
Millennium Management
New York
$529K -$1.86M -337,661 -75%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$518K -$84K -15,231 -12%
Barclays
42
Barclays
United Kingdom
$517K +$225K +40,787 +61%
TD Asset Management
43
TD Asset Management
Ontario, Canada
$510K -$186K -33,800 -24%
PCMI
44
Paradigm Capital Management Inc
New York
$481K +$306K +55,400 +124%
Swiss National Bank
45
Swiss National Bank
Switzerland
$466K – – –
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$453K +$7.57K +1,372 +1%
UBS Group
47
UBS Group
Switzerland
$441K +$171K +31,044 +51%
WMSA
48
Weiss Multi-Strategy Advisers
New York
$433K – – –
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$417K +$15.3K +2,773 +3%
SSA
50
Schonfeld Strategic Advisors
New York
$403K +$339K +61,400 +273%
1
2
3 4 5

GNMK Hedge Fund Activity: Q4 2019 in Review

111 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2019, worth a combined $266M — down 17% from $320M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 49 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.79M. The largest seller was T. Rowe Price Associates, cutting an estimated $4.89M.

  • 111 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2019, up from 110 in Q3 2019.
  • Funds reported $266M of GenMark Diagnostics, Inc stock for Q4 2019, down 17% quarter-over-quarter.
  • 10 funds opened new GenMark Diagnostics, Inc positions in Q4 2019 and 9 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2019 was Morgan Stanley, an estimated $5.79M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2019 was T. Rowe Price Associates, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2019.